Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20362635 | 0.96 | HIF1A (0.43) | HIF1ATSHRLMNATRPV1FAAH | |
| SCHEMBL1782964 | 0.93 | HIF1A (0.46) | HIF1ATSHRLMNATRPV1FAAH | |
| SCHEMBL1784052 | 0.87 | HIF1A (0.40) | HIF1ATSHRADH1BADH1CADH1A | |
| SCHEMBL3408019 | 0.85 | HIF1A (0.45) | HIF1ATSHRLMNATRPV1FAAH | |
| SCHEMBL1782961 | 0.82 | HIF1A (0.43) | HIF1ATSHRTRPV1FAAHALDH1A1 | |
| SCHEMBL28922962 | 0.81 | LMNA (0.59) | HIF1ATSHRLMNATRPV1FAAH | |
| SCHEMBL585190 | 0.81 | LMNA (0.59) | HIF1ATSHRLMNATRPV1FAAH | |
| SCHEMBL1782837 | 0.81 | LMNA (0.46) | HIF1ATSHRLMNATRPV1FAAH | |
| SCHEMBL15625952 | 0.80 | HIF1A (0.42) | HIF1ATSHRTRPV1FAAHALDH1A1 | |
| SCHEMBL214883 | 0.80 | HIF1A (0.33) | HIF1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160326278-A1 | AMINATION OF POLYMERS TERMINATED WITH ALDEHYDE GROUP AND THEIR FUNCTIONALIZED DERIVATIVES FOR FOULING MITIGATION IN HYDROCARBON REFINING PROCESSES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2016-11-10 | — | — | US | disclosed |
| US-20160326278-A1 | AMINATION OF POLYMERS TERMINATED WITH ALDEHYDE GROUP AND THEIR FUNCTIONALIZED DERIVATIVES FOR FOULING MITIGATION IN HYDROCARBON REFINING PROCESSES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2016-11-10 | — | — | US | disclosed |
| US-20160160071-A1 | Water-Based Polyolefin Corrosion Inhibitors Based on Vinyl/Vinylidene Terminated Polyolefins | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-06-09 | — | — | US | disclosed |
| US-20140275433-A1 | AMINATION OF POLYMERS TERMINATED WITH ALDEHYDE GROUP AND THEIR FUNCTIONALIZED DERIVATIVES FOR FOULING MITIGATION IN HYDROCARBON REFINING PROCESSES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-09-18 | — | — | US | disclosed |
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| CN-101583587-B | Process for preparing polyalcohols from formaldehyde with a low formic acid content | BASF SE | 2012-08-08 | — | — | CN | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| CN-101583587-A | Process for preparing polyalcohols from formaldehyde with a low formic acid content | BASF SE (DE) | 2009-11-18 | — | — | CN | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
| US-7462747-B2 | of by-products can advantageously be prevented in a targeted manner and the yield of the desired polymethylol compound can thereby be increased; condensing an aldehyde with formaldehyde in an aldol reaction to form an alkanal, hydrogenating the alkanal | BASF AKTIENGESELLSCHAFT (DE) | 2008-12-09 | — | — | US | disclosed |
| US-20080167506-A1 | of by-products can advantageously be prevented in a targeted manner and the yield of the desired polymethylol compound can thereby be increased; condensing an aldehyde with formaldehyde in an aldol reaction to form an alkanal, hydrogenating the alkanal | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| US-7186782-B2 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2007-03-06 | — | — | US | disclosed |
| US-20060041079-A1 | Hydrogenation catalyst composition and process for hydrogenation of conjugated diene polymer | TSRC CORPORATION | 2006-02-23 | — | — | US | disclosed |
| US-6881797-B2 | Process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2005-04-19 | — | — | US | disclosed |
| US-20040082727-A1 | Process for hydrogenation of conjugated diene polymer | TSRC CORPORATION (CN) | 2004-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167506-A1 | of by-products can advantageously be prevented in a targeted manner and the yield of the desired polymethylol compound can thereby be increased; condensing an aldehyde with formaldehyde in an aldol reaction to form an alkanal, hydrogenating the alkanal | ASH2L, AKR7A2, HACL2 | HIF1A 1662/4885TSHR 4634/4885LMNA 1141/4885 |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | HIF1A 1980/4885TSHR 2479/4885LMNA 1708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.